- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03338192
Examining Racial and SocioEconomic Disparities (ERASED) in Chronic Low Back Pain Study (ERASED)
Racial and Socioeconomic Differences in Chronic Low Back Pain
Study Overview
Detailed Description
Experimental session 1
Resting Blood Pressure and Body Mass Index will be assessed. Participants will complete the Rapid Estimation of Adult Literacy Measure-Short Form (REALM-SF) to determine health literacy. Participants will complete multiple questionnaires to measure Socioeconomic Status, Clinical Pain Assessment and Depression Scale. All participants will undergo quantitative sensory testing for assessment of endogenous pain modulation using painful heat, mechanical, and cold stimuli in a laboratory session lasting approximately 1 hour.
Between Experimental Session 1 and Experimental Session 2
Sleep assessment: Sleep data will be collected by participants in their own homes using objective and subjective measures of their sleep. Participant instructions for how to collect and record their own sleep data will be provided at the end of study session 1.
Experimental Session 2
Experimental session 2 will take place in the CCTS Clinical Research Unit (CRU) All blood will be collected as part of a single draw by research nurses. Participants will complete multiple questionnaires to measure Clinical Pain Assessment and Coping Strategies. Participants will then complete a battery of ecologically valid movement tasks that include: 1) getting in and out of a bed; 2) sitting in a chair, transitioning to a standing position, and then sitting again, and 3) lifting, Performance Battery (SPPB) and the Timed Up and Go test (TUG). Blood will be processed and stored and then used to measure Vitamin D, CRP assays and Oxytocin. Finally follow up data will be collected by phone once per week for four weeks following the completion of study session 2.
Study Type
Enrollment (Actual)
Contacts and Locations
Study Contact
- Name: Burel Goodin, PhD
- Phone Number: (205) 934-8910
- Email: bgoodin1@uab.edu
Study Contact Backup
- Name: Tammie Quinn, BA
- Phone Number: (205) 356-1730
- Email: tquinn@uab.edu
Study Locations
-
-
Alabama
-
Birmingham, Alabama, United States, 35294
- UAB
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- Chronic low back pain that has been going on consistently for the last 6 months.
Exclusion Criteria:
- Surgery (fusion, Laminectomy) in the last year, accident or trauma in the last year, uncontrolled high blood pressure, heart disease, cancer, diabetes HbA1c > 7%, Ankylosing Spondylitis, Infection, Parkinson's Disease, Multiple Sclerosis, Epilepsy, Stroke, Seizure (non-epileptic), Systemic Lupus Erythematosus, Fibromyalgia, Raynaud's disease, Major Depression/Bipolar Disorder, HIV
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
African American/Black QST
This group will consist of a full range of socioeconomic status in African American/Black individuals with chronic low back pain.
|
All participants will undergo quantitative sensory testing for assessment of endogenous pain modulation using painful heat, mechanical, and cold stimuli in a laboratory session lasting approximately 1 hour.
|
Caucasian/White QST
This group will consist of a full range of socioeconomic status in Caucasian/White individuals with chronic low back pain.
|
All participants will undergo quantitative sensory testing for assessment of endogenous pain modulation using painful heat, mechanical, and cold stimuli in a laboratory session lasting approximately 1 hour.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Clinical Pain Severity
Time Frame: Baseline to one week.
|
Participants will self-report a number between 0 - 100 describing the intensity of their low back pain, such that 0 = no pain and 100 = the most intense pain imaginable.
Any integer from 0 to 100 can be provided.
|
Baseline to one week.
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Pain threshold
Time Frame: Baseline
|
Pain threshold refers to the intensity at which a stimulus is first perceived as painful.
Heat stimuli will be delivered using a computer-controlled thermal stimulation system with a 30 millimeter X 30 millimeter probe.
From a baseline of 32 degrees Celsius, the probe temperature will increase at a rate of .5 degrees Celsius/second until the participant responds by pressing a button on a handheld device.
For heat pain threshold, participants will be instructed to press the button when the sensation "first becomes painful"
|
Baseline
|
Pain tolerance
Time Frame: Baseline
|
Pain tolerance refers to the maximum amount of pain produced by a stimulus that a person is able/willing to tolerate.
Heat stimuli will again be delivered using the computer-controlled thermal stimulation system.
From a baseline of 32 degrees Celsius, the probe temperature will increase at a rate of .5 degrees Celsius/second until the participant responds by pressing a button on a handheld device.
For heat pain tolerance, participants will be instructed to press the button when they are "no longer willing to tolerate" the painful sensation.
|
Baseline
|
Temporal summation of pain
Time Frame: Baseline
|
Temporal summation of pain refers to a form of endogenous pain facilitation characterized by the perception of increased pain despite constant or even reduced peripheral afferent input.
Temporal summation is presumed to be the psychophysical manifestation of wind-up.
Wind-up is a phenomenon where repetitive stimulation of C primary afferents at rates greater than 0.3 Hertz produces a slowly increasing response of second-order neurons in the spinal cord.
|
Baseline
|
Conditioned pain modulation
Time Frame: Baseline
|
A routinely used quantitative sensory testing protocol for the measurement of endogenous pain inhibition is conditioned pain modulation, which refers to the reduction in pain from one stimulus (the test stimulus) produced by the application of a second pain stimulus at a remote body site (the conditioning stimulus).
Conditioned pain modulation is believed to reflect the perceptual manifestation of diffuse noxious inhibitory controls, whereby ascending projections from one noxious stimulus activate supraspinal structures that trigger descending inhibitory projections to the dorsal horn.
|
Baseline
|
C-reactive protein
Time Frame: One week follow up
|
A marker of systemic pro-inflammation
|
One week follow up
|
Fibrinogen
Time Frame: One week follow up
|
A marker of systemic pro-inflammation
|
One week follow up
|
Serum amyloid A
Time Frame: One week follow up
|
A marker of systemic pro-inflammation
|
One week follow up
|
Vitamin D
Time Frame: One week follow up
|
hormone
|
One week follow up
|
Oxytocin
Time Frame: One week follow up
|
Hormone
|
One week follow up
|
Sleep quality
Time Frame: Between baseline and one week follow-up
|
Measured via actigraphy
|
Between baseline and one week follow-up
|
Self-reported disability
Time Frame: One week follow up
|
To be assessed with the Oswestry Low Back Pain Questionnaire.
This measure is patient-completed questionnaire which gives a subjective percentage score of level of function (disability) in activities of daily living in those with low back pain.
|
One week follow up
|
Evoked pain with movement
Time Frame: One week follow up
|
Participants will complete a serious of movements including getting in and out of bed as well as lifting a crate from the ground to a tabletop.
They will provide a rating from 0 - 100 indicating how painful it was to complete each movement (0 = no pain, 100 = most intense pain imaginable).
|
One week follow up
|
Functional performance
Time Frame: One week follow up
|
Participants will complete the short physical performance battery.
This assessment represents is a group of measures that combines the results of the gait speed, chair stand and balance tests.
|
One week follow up
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Depressive symptoms
Time Frame: Baseline
|
Measured using the Center for Epidemiological Studies - Depression Scale
|
Baseline
|
Perceived injustice
Time Frame: Baseline
|
Measured using the Injustice Experiences Questionnaire
|
Baseline
|
Perceived discrimination
Time Frame: Baseline
|
Measured using the Everyday Discrimination Scale
|
Baseline
|
Social support
Time Frame: Baseline
|
Measured using the Multidimensional Survey of Perceived Social Support Scale
|
Baseline
|
Psychological pain resilience
Time Frame: Baseline
|
Measured using the Psychological Pain Resilience Scale
|
Baseline
|
Dietary caffeine consumption
Time Frame: Between baseline and one week follow up
|
Measured using a daily diary of dietary intake across seven days
|
Between baseline and one week follow up
|
Collaborators and Investigators
Investigators
- Principal Investigator: Burel Goodin, PhD, University of Alabama at Birmingham Department of Psychology
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- F170119003
- R01MD010441 (U.S. NIH Grant/Contract)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Back Pain Lower Back Chronic
-
Neuronoff, IncOhio Pain ClinicCompletedChronic Pain | Lower Back Pain ChronicUnited States
-
Cedars-Sinai Medical CenterNational Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)Completed
-
Canandaigua VA Medical CenterFoot Levelers, Inc.; Northeast College of Health SciencesTerminatedBack Pain Lower Back ChronicUnited States
-
University of MichiganRecruiting
-
New York Institute of TechnologyRecruitingChronic Lower Back PainUnited States
-
AppliedVR Inc.Completed
-
Stanford UniversityNot yet recruitingLower Back Pain Chronic
-
Canandaigua VA Medical CenterCompletedChronic Lower Back PainUnited States
-
Rigshospitalet, DenmarkHerlev HospitalActive, not recruitingLower Back Pain ChronicDenmark
-
Canandaigua VA Medical CenterCompleted
Clinical Trials on QST
-
Parc de Salut MarCompletedKnee OsteoarthritisSpain
-
University of KielUnknownNeuropathic Pain | Peripheral Nerve Injury | Polyneuropathy
-
Ruhr University of BochumCompleted
-
Ahram Canadian UniversityRecruitingCarpal Tunnel SyndromeEgypt
-
Assistance Publique - Hôpitaux de ParisAssociation de patients : association sclérodermies de FranceCompletedScleroderma, Systemic | Scleroderma, DiffuseFrance
-
University of KielInstitut National de la Santé Et de la Recherche Médicale, France; Aarhus University... and other collaboratorsCompleted
-
M.D. Anderson Cancer CenterNational Institute of Dental and Craniofacial Research (NIDCR)Active, not recruiting
-
University of ZurichUnknownCluster HeadacheSwitzerland
-
Massachusetts General HospitalCompletedRadiculopathy | Lower Extremity Radicular PainUnited States
-
University of MichiganCompleted